137 related articles for article (PubMed ID: 11659897)
1. Doctor charged over growth hormone payments.
Kiernan V
New Sci; 1994 Aug; 143(1939):6. PubMed ID: 11659897
[No Abstract] [Full Text] [Related]
2. A doctor's drug studies turn into fraud.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():A1, A16. PubMed ID: 11647660
[No Abstract] [Full Text] [Related]
3. Selling growth drug for children: the legal and ethical questions.
Kolata G
N Y Times Web; 1994 Aug; ():A1, A13. PubMed ID: 11647981
[No Abstract] [Full Text] [Related]
4. All expenses paid, Doctor.
Greenberg DS
Lancet; 1990 Dec 22-29; 336(8730):1568-9. PubMed ID: 11653929
[No Abstract] [Full Text] [Related]
5. Are short kids 'sick'.
Weiss R
Washington Post; 1994 Mar; ():Health, 10-3. PubMed ID: 11647964
[No Abstract] [Full Text] [Related]
6. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
7. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
8. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
9. Kennedy hearings say no more free lunch--or much else--from drug firms.
Randall T
JAMA; 1991 Jan 23-30; 265(4):440, 442. PubMed ID: 1985222
[No Abstract] [Full Text] [Related]
10. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
11. Super athletes made to order.
Taylor WN
Psychol Today; 1985 May; 19(5):62-6. PubMed ID: 11658564
[No Abstract] [Full Text] [Related]
12. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
13. Federal agency revises rule on financial disclosure by researchers.
Maloney DM
Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
[No Abstract] [Full Text] [Related]
14. Draft policy statement on industry-supported scientific and educational activities; notice.
U.S. Food and Drug Administration
Fed Regist; 1992 Nov; 57(229):56412-4. PubMed ID: 11645753
[No Abstract] [Full Text] [Related]
15. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
Samuels A
Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
[No Abstract] [Full Text] [Related]
16. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
Salbu SR
Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141
[No Abstract] [Full Text] [Related]
17. Doctors dropping Medicare patients.
Freudenheim M
N Y Times Web; 1992 Apr; ():1, 26. PubMed ID: 11647927
[No Abstract] [Full Text] [Related]
18. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
19. Legal trends in bioethics.
Davis DS
J Clin Ethics; 1994; 5(4):367-8. PubMed ID: 11644649
[No Abstract] [Full Text] [Related]
20. Research project on ear infections dramatizes challenge of conflicts.
Cordes C
Chron High Educ; 1993 Mar; 39(26):A23, A28. PubMed ID: 11656295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
